SCHEMBL7828008

SCHEMBL7828008

CCCCc1nc(Cl)c(C=O)n1Cc1ccc(CC(=O)O)cc1

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.64
AGTR2 P50052 4/20 0.64
GP6 Q9HCN6 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9010378 0.88 AGTR1 (0.59) AGTR1AGTR2GP6
SCHEMBL965839 0.87 AGTR1 (0.67) AGTR1AGTR2GP6
SCHEMBL18003201 0.87 AGTR1 (0.61) AGTR1AGTR2GP6
SCHEMBL9010382 0.84 AGTR1 (0.60) AGTR1AGTR2GP6
SCHEMBL8568897 0.84 AGTR1 (0.59) AGTR1AGTR2GP6
SCHEMBL28517678 0.84 AGTR1 (0.59) AGTR1AGTR2GP6
SCHEMBL4639444 0.84 AGTR1 (0.59) AGTR1AGTR2GP6
SCHEMBL9152560 0.84 AGTR1 (0.62) AGTR1AGTR2GP6
SCHEMBL3872329 0.84 AGTR1 (0.59) AGTR1AGTR2GP6
SCHEMBL3324054 0.83 AGTR1 (0.59) AGTR1AGTR2GP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513533-B1 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application BAYER AG (DE) 2001-11-21 EP disclosed
EP-1127880-A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation BAYER AG (DE) 2001-08-29 EP disclosed
US-5521206-A HYPOTENSIVE AGENTS, TREATMENT OF ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed
EP-0513533-A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application BAYER AG (DE) 1992-11-19 EP disclosed